Laboratory evaluation of the efficacy of lotilaner (Credelio™) against Haemaphysalis longicornis infestations of dogs

• Published in: Parasites & vectors Vol. 11; no. 1; p. 448
• Main Authors: Otaki, Hiroshi, Sonobe, Junko, Murphy, Martin, Cavalleri, Daniela, Seewald, Wolfgang, Drake, Jason, Nanchen, Steve
• Format: Journal Article
• Language: English
• Published: England BioMed Central Ltd 02.08.2018; BioMed Central; BMC
• Subjects: Acaricides - therapeutic use; Anaemia; Anemia; Animals; Arachnids; Babesia gibsoni; Care and treatment; Collars; Completeness; Control; Credelio; Development and progression; Dog; Dog diseases; Dog Diseases - drug therapy; Dog Diseases - parasitology; Dogs; Dosage; Effectiveness; Efficacy; Evaluation; Female; Haemaphysalis longicornis; Hard ticks; Health aspects; Infestation; Insecticides; Ixodidae - drug effects; Laboratories; Lotilaner; Male; Paralysis; Parasitology; Statistical analysis; Tablets; Tick Control; Tick Infestations - drug therapy; Tick Infestations - parasitology; Tick Infestations - veterinary; Ticks; Vectors; Efficacy; Haemaphysalis longicornis; Credelio; Lotilaner; Dog; Ticks
• ISSN: 1756-3305; 1756-3305
• DOI: 10.1186/s13071-018-3032-0

Throughout Japan, Korea and China, Haemaphysalis longicornis ticks are vectors of Babesia gibsoni, which causes severe and progressive anemia in dogs. This study evaluated the efficacy of a single administration of lotilaner flavored chewable tablets (Credelio ) against experimental canine H. longicornis infestations. Twenty-two healthy Beagles were ranked in descending order of counts of H. longicornis completed 48 h after challenge on Day -7. The 16 dogs with the highest live tick counts were blocked into pairs and within pairs randomized to either lotilaner-treatment at a minimum dose rate of 20 mg/kg or sham-treated controls. Treatment was administered within 30 ± 5 min following feeding on Day 0. Infestations with 50 unfed adult H. longicornis were completed on Days -2, 7, 14, 21, 28 and 35. Elizabethan collars were placed for 48 (± 2) h after each infestation and a T-shirt was placed on each dog to facilitate attachment. Ticks were counted in situ 12 and 24 h post-treatment and counted and removed after an additional 24 h (48 h after treatment) and 48 h after each post-treatment infestation. Dogs were sedated for tick challenges and counts. Live attached ticks on each dog were counted for efficacy assessments. Lotilaner was considered effective if the average tick attachment rate in the control group was at least 20%, if there was a statistically significant difference (P < 0.05) in mean tick counts between treated and control groups, and if the lotilaner-treated group had a calculated efficacy of at least 90%. Average control group retention of the H. longicornis challenge exceeded 20% at each assessment. Lotilaner started killing H. longicornis ticks quickly, achieving 57.4% efficacy within 12 h. At 48 h post-treatment, and following each subsequent infestation, between-group differences in mean H. longicornis counts were significant (P < 0.0001). From 48 h post-treatment, through the final assessment on Day 37, lotilaner efficacy remained greater than 95%, including on Day 37 when efficacy was 98.4%. Lotilaner, administered to dogs orally at a minimum dose rate of 20 mg/kg is well tolerated, provides rapid reduction of existing H. longicornis tick infestations, and provides sustained residual protection for at least 35 days.